Company Profile

BioChain Institute Inc
Profile last edited on: 6/17/11      CAGE: 4L5W3      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1994
First Award
2008
Latest Award
2008
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3517 Breakwater Avenue
Hayward, CA 94545
   (510) 783-8588
   order@biochain.com
   www.biochain.com
Location: Single
Congr. District: 15
County: Alameda

Public Profile

BioChain supplies more than 5,000 ready-to-use products, including reagents and kits for extraction, purification, and analysis, as well as our custom designed products and services, we are enabling biomedical researchers to conduct their experiments and/or develop their assays with unprecedented efficiency. Technology innovation and development are the driving forces behind the steady growth of BioChain. We have developed many patented technologies, such as ultraspeed cloning checker, compartment protein isolation, high throughput Western blot, and integrated bioarray. We also developed technologies for isolating DNA, RNA and protein simultaneously from the same biological sample. We have advanced protein detection by our patented Enhancer for Western Analysis and GEMPLA technology. In addition to our in-house technology development, we have expanded our intellectual property portfolios by licensing third-party technologies and forming partnerships. We recently licensed a patented technology to knockout protein(s) in vivo. We also formed partnership with several leading companies to provide our customers with antibody production offerings

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2008 1 NIH $143,168
Project Title: A Novel Treatment To Target Tumor Mass For Eradicating Metastasis

Key People / Management

  Yun Bao

Company News

There are no news available.